Opticept Technologies AB
STO:OPTI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.43
6.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one OPTI stock under the Base Case scenario is 2.61 SEK. Compared to the current market price of 2.43 SEK, Opticept Technologies AB is Undervalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Opticept Technologies AB.
| JP |
I
|
Ishii Iron Works Co Ltd
TSE:6362
|
|
| US |
|
Parker-Hannifin Corp
NYSE:PH
|
|
| SE |
|
Atlas Copco AB
STO:ATCO A
|
|
| JP |
|
Mitsubishi Heavy Industries Ltd
TSE:7011
|
|
| US |
|
Barnes Group Inc
NYSE:B
|
|
| US |
|
Illinois Tool Works Inc
NYSE:ITW
|
|
| CH |
|
Schindler Holding AG
SIX:SCHP
|
|
| SE |
|
Sandvik AB
STO:SAND
|
|
| FI |
K
|
Kone Oyj
OMXH:KNEBV
|
|
| JP |
|
Fanuc Corp
TSE:6954
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Opticept Technologies AB
Balance Sheet Decomposition
Opticept Technologies AB
| Current Assets | 64.5m |
| Cash & Short-Term Investments | 12m |
| Receivables | 6m |
| Other Current Assets | 46.5m |
| Non-Current Assets | 318.1m |
| Long-Term Investments | 6k |
| PP&E | 5.5m |
| Intangibles | 312.4m |
| Other Non-Current Assets | 161k |
| Current Liabilities | 45.2m |
| Accounts Payable | 3.5m |
| Accrued Liabilities | 12.9m |
| Short-Term Debt | 15.2m |
| Other Current Liabilities | 13.5m |
| Non-Current Liabilities | 5.4m |
| Long-Term Debt | 3.2m |
| Other Non-Current Liabilities | 2.2m |
Free Cash Flow Analysis
Opticept Technologies AB
| SEK | |
| Free Cash Flow | SEK |
Earnings Waterfall
Opticept Technologies AB
|
Revenue
|
15.7m
SEK
|
|
Cost of Revenue
|
-3.6m
SEK
|
|
Gross Profit
|
12.1m
SEK
|
|
Operating Expenses
|
-75.2m
SEK
|
|
Operating Income
|
-63.1m
SEK
|
|
Other Expenses
|
-2.5m
SEK
|
|
Net Income
|
-65.6m
SEK
|
OPTI Profitability Score
Profitability Due Diligence
Opticept Technologies AB's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Opticept Technologies AB's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
OPTI Solvency Score
Solvency Due Diligence
Opticept Technologies AB's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Opticept Technologies AB's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OPTI Price Targets Summary
Opticept Technologies AB
According to Wall Street analysts, the average 1-year price target for OPTI is 4.85 SEK with a low forecast of 4.8 SEK and a high forecast of 4.99 SEK.
Dividends
Current shareholder yield for OPTI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one OPTI stock under the Base Case scenario is 2.61 SEK.
Compared to the current market price of 2.43 SEK, Opticept Technologies AB is Undervalued by 7%.